Banner

Lung fibrosis, also known as pulmonary fibrosis, is a chronic lung disease characterized by the formation of excessive scar tissue in the lungs. This can lead to breathing difficulties and a decreased ability to exchange oxygen and carbon dioxide. It can be caused by various factors, such as exposure to certain toxins, infections, or autoimmune diseases.

Reprinted from Nature Reviews Disease Primers, 3, Martinez FJ, Collard HR, Pardo A, et al. idiopathic pulmonary fibrosis, 17074, 2017, with permission from Springer Nature.Figure 1. Reprinted from Nature Reviews Disease Primers, 3, Martinez FJ, Collard HR, Pardo A, et al. idiopathic pulmonary fibrosis, 17074, 2017, with permission from Springer Nature.

In drug screening for lung fibrosis, in vitro cell models can be used to evaluate the efficacy and safety of potential therapeutic drugs. Creative Bioarray offers a TGF-β-induced fibrosis model using lung cells for researchers studying pulmonary fibrosis and related diseases. Researchers can then expose these cells to various compounds, including potential drug candidates, to assess their effect on fibrosis-related processes.

TGF-β-induced Fibrosis on Lung Cells

Fibroblast-to-myofibroblast transition (FMT)Fibroblast-to-myofibroblast transition (FMT)

Epithelial-to-mesenchymal transition (EMT)Epithelial-to-mesenchymal transition (EMT)

In vitro Models of Lung Fibrosis

  • 2D Culture Models:
    Primary lung fibroblast cultures
    Lung epithelial cell cultures
  • Co-culture Models
  • 3D Culture Models

Endpoints

  • Image analysis
  • Evaluation of Fibroblast-to-myofibroblast transition (FMT) biomarkers
  • Evaluation of Epithelial-to-mesenchymal transition (EMT) biomarkers

Study Examples:

TGF-Beta1-induced miR-133a blocks pulmonary fibroblast differentiation.Figure 2. TGF-β1-induced miR-133a blocks pulmonary fibroblast differentiation. [2]

References:

1. Martinez, Fernando J et al. "Idiopathic pulmonary fibrosis." Nature reviews. Disease primers vol. 3 17074. 20 Oct. 2017, doi:10.1038/nrdp.2017.74

2. Wei, Peng et al. "Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis." Cell death & disease vol. 10,9 670. 11 Sep. 2019, doi:10.1038/s41419-019-1873-x

* For scientific research only

Online Inquiry